Related references
Note: Only part of the references are listed.Identifying Therapies to Combat Epithelial Mesenchymal Plasticity-Associated Chemoresistance to Conventional Breast Cancer Therapies Using An shRNA Library Screen
Sugandha Bhatia et al.
CANCERS (2020)
Using antagonistic pleiotropy to design a chemotherapy-induced evolutionary trap to target drug resistance in cancer
Kevin H. Lin et al.
NATURE GENETICS (2020)
New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression
Sugandha Bhatia et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2020)
Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
Irem Ozkan-Dagliyan et al.
CELL REPORTS (2020)
Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI
Chien-Hui Weng et al.
ONCOGENE (2019)
FAT4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis
Ran Wei et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture
Eirikur Briem et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2019)
Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition
Yoko Katsuno et al.
SCIENCE SIGNALING (2019)
Targeting the PI3-kinase pathway in triple-negative breast cancer
J. Pascual et al.
ANNALS OF ONCOLOGY (2019)
Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens
Fiona M. Behan et al.
NATURE (2019)
Phenotypic Plasticity: Driver of Cancer Initiation, Progression, and Therapy Resistance
Piyush B. Gupta et al.
CELL STEM CELL (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Alisertib in Combination With Weekly Paclitaxel in Patients With Advanced Breast Cancer or Recurrent Ovarian Cancer A Randomized Clinical Trial
Gerald Falchook et al.
JAMA ONCOLOGY (2019)
Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Clinical Practice Guideline Focused Update
Neelima Denduluri et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Phase I/II clinical trial of everolimus combined with gemcitabine/cisplatin for metastatic triple-negative breast cancer
In Hae Park et al.
JOURNAL OF CANCER (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Altered plasmalogen content and fatty acid saturation following epithelial to mesenchymal transition in breast epithelial cell lines
Finnur Freyr Eiriksson et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Differentiation-state plasticity is a targetable resistance mechanism in basal-like breast cancer
Tyler Risom et al.
NATURE COMMUNICATIONS (2018)
The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2017)
被撤回的出版物: SB-T-121205, a next-generation taxane, enhances apoptosis and inhibits migration/invasion in MCF-7/PTX cells (Retracted article. See vol. 63, pg. 104, 2023)
Xiaowei Zheng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells
Robin M. Meyers et al.
NATURE GENETICS (2017)
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
N. Masuda et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Fatty acid synthase - Modern tumor cell biology insights into a classical oncology target
Douglas Buckley et al.
PHARMACOLOGY & THERAPEUTICS (2017)
The Cellular Origin and Evolution of Breast Cancer
Mei Zhang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Cancer cells exhibit clonal diversity in phenotypic plasticity
Robert Austin Mathis et al.
OPEN BIOLOGY (2017)
Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer The Randomized Clinical FinXX Trial
Heikki Joensuu et al.
JAMA ONCOLOGY (2017)
Metformin inhibits TGF-β1-induced epithelial-to-mesenchymal transition-like process and stem-like properties in GBM via AKT/mTOR/ZEB1 pathway
Yang Song et al.
Oncotarget (2017)
Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition
Skarphedinn Halldorsson et al.
CANCER LETTERS (2017)
HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR
S. Ingthorsson et al.
ONCOGENE (2016)
Targeting mTOR pathway inhibits tumor growth in different molecular subtypes of triple-negative breast cancers
Rana Hatem et al.
ONCOTARGET (2016)
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
Konstantinos Tzelepis et al.
CELL REPORTS (2016)
EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT
Kumari Sonal Choudhary et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
The multifaceted roles of fatty acid synthesis in cancer
Florian Roehrig et al.
NATURE REVIEWS CANCER (2016)
Fasnall, a Selective FASN Inhibitor, Shows Potent Anti-tumor Activity in the MMTV-Neu Model of HER2+ Breast Cancer
Yazan Alwarawrah et al.
CELL CHEMICAL BIOLOGY (2016)
High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
Traver Hart et al.
CELL (2015)
Characterization of Durable Responder for Capecitabine Monotherapy in Patients With Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer
Jung Yong Hong et al.
Clinical Breast Cancer (2015)
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
Identification and characterization of essential genes in the human genome
Tim Wang et al.
SCIENCE (2015)
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
Aaron Goldman et al.
NATURE COMMUNICATIONS (2015)
Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR
Wei Li et al.
GENOME BIOLOGY (2015)
Fatty Acid Synthase Mediates the Epithelial-Mesenchymal Transition of Breast Cancer Cells
Junqin Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li et al.
GENOME BIOLOGY (2014)
Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis
Denise A. Yardley et al.
ADVANCES IN THERAPY (2013)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
Neil E. Bhola et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Acquisition of epithelial-mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance
L. Chang et al.
CELL DEATH & DISEASE (2013)
Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
Taru Muranen et al.
CANCER CELL (2012)
Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells
Mayu Yunokawa et al.
CANCER SCIENCE (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Regulation of EMT by TGFβ in cancer
Carl-Henrik Heldin et al.
FEBS LETTERS (2012)
Defining the E-Cadherin Repressor Interactome in Epithelial-Mesenchymal Transition: The PMC42 Model as a Case Study
Honor J. Hugo et al.
CELLS TISSUES ORGANS (2011)
Endothelial Induced EMT in Breast Epithelial Cells with Stem Cell Properties
Valgardur Sigurdsson et al.
PLOS ONE (2011)
An EMT-Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype
Irina M. Shapiro et al.
PLOS GENETICS (2011)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
A probability-based approach for the analysis of large-scale RNAi screens
Renate Koenig et al.
NATURE METHODS (2007)
Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway
Samy Lamouille et al.
JOURNAL OF CELL BIOLOGY (2007)
Immortalization protocols used in cell culture models of human breast morphogenesis
T Gudjonsson et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2004)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties
T Gudjonsson et al.
GENES & DEVELOPMENT (2002)
Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5
TM Kapoor et al.
JOURNAL OF CELL BIOLOGY (2000)
Share Paper
